TRPV1 and serum lipopolysaccharide activity: TRPV1 endogenous agonists such as N-oleoyldopamine (OLDA) induce IL-10 by activating TRPV1 in the central nervous system to reduce inflammatory responses and improve endotoxemia and sepsis outcomes (52).